When your physician discovers a spot or small mass in your lung, you may need to undergo a diagnostic procedure called a bronchoscopy to determine what it is. Sometimes lung nodules can be very small and located in a hard-to-reach area of the lung. In these cases, a robotic-assisted bronchoscopy procedure like the MONARCH® Platform may be recommended.
Leading up to your procedure with the MONARCH® Platform, you may have several questions. Our goal is to inform you about robotic-assisted bronchoscopy.
We have listed the most common questions and answers.
Your doctor will insert a thin tube called a bronchoscope through your mouth and throat into the lung and take a tissue sample of the nodule. The sample will be sent to a laboratory to find out more information about your nodule.
When you hear the term “robotic bronchoscopy,” it’s not uncommon to wonder if your bronchoscopy will be performed by a robot. While the MONARCH® Platform does utilize breakthrough robotic technology, you can rest assured that your procedure will not be performed by a robot.
A robotic-assisted bronchoscopy is completely controlled and navigated by a highly skilled medical professional, but the robotic technology is designed to provide greater precision and cutting-edge navigation to help your physician reach small nodules. The MONARCH® technology helps your physician map out a pathway to the nodule so that he or she never loses sight of the path ahead.
If you or a loved one has a nodule in a hard-to-reach area of the lung, robotic bronchoscopy may be able to provide you a safe and effective way of getting an efficient diagnosis. Ask your doctor if this procedure is right for you, or contact one of our medical partners to schedule a consultation.
Biopsy samples taken with MONARCH’s bronchoscopy platform are often tested using rapid on-site evaluation (ROSE). ROSE means the physician will have the tissue tested during the procedure. Because the necessary tissue samples are obtained during the procedure, a second bronchoscopy is rarely needed.
Bronchoscopy Important Safety Statement:
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Urology Important Safety Statement:
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.